afm-13
artiva biotherapeutics,affimed
['ptcl', 'afm13 ', 'lymphoma', 'affimed', 'artiva']
today, we announced 2 important data sets: topline data from our monotherapy phase 2 redirect trial in r/r ptcl patients &amp; data from our study with evaluating the combination of afm13 with nk cells. more here: #ash22 
We are a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer.